Literature DB >> 7926365

Interactions between B lymphocytes and NK cells.

D Yuan1, C Y Koh, J A Wilder.   

Abstract

The ability of natural killer (NK) cells to secrete lymphokines confers upon them the potential to regulate cell types via mechanisms other than direct cytotoxicity. During the past few years increasing evidence has been accumulating to show that NK and B cells can interact productively. First, NK cells cocultured with B cells can induce them to initiate polyclonal Ig secretion. This help is mediated by a soluble factor (or factors) that appears to be different from any known cytokine. Second, preactivated B lymphocytes can induce NK cells to produce greater amounts of IFN-gamma via an interaction that requires direct cell contact. Third, in contrast to previous suggestions, NK cells do not have the ability to kill primary B lymphocytes regardless of their stage of differentiation. Evaluation of the in vivo relevance of these interactions revealed that activated NK cells can increase the IgG2a response to a specific protein antigen. Without activation, NK cells neither enhance nor inhibit B cell responses to antigens. The deviation of the isotype distribution may allow increased NK cell specificity for certain pathogens by enhancing antibody-dependent cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926365     DOI: 10.1096/fasebj.8.13.7926365

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  13 in total

1.  Immuno-inflammatory cell dynamics during cutaneous wound healing.

Authors:  A D Agaiby; M Dyson
Journal:  J Anat       Date:  1999-11       Impact factor: 2.610

2.  Mitogenicity of the recombinant mycobacterial 27-kilodalton lipoprotein is not connected to its antiprotective effect.

Authors:  Avi-Hai Hovav; Liuba Davidovitch; Gabriel Nussbaum; Jacob Mullerad; Yolanta Fishman; Herve Bercovier
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

Review 3.  Regulation of adaptive immunity by natural killer cells.

Authors:  F J Kos
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

4.  The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.

Authors:  Preeti Chhabra; Joel Linden; Peter Lobo; Mark Douglas Okusa; Kenneth Lewis Brayman
Journal:  Curr Diabetes Rev       Date:  2012-11

Review 5.  The role of natural killer cells in tumor control--effectors and regulators of adaptive immunity.

Authors:  Morgan E Wallace; Mark J Smyth
Journal:  Springer Semin Immunopathol       Date:  2005-02-24

6.  Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys.

Authors:  Nicolas Huot; Beatrice Jacquelin; Thalia Garcia-Tellez; Philippe Rascle; Mickaël J Ploquin; Yoann Madec; R Keith Reeves; Nathalie Derreudre-Bosquet; Michaela Müller-Trutwin
Journal:  Nat Med       Date:  2017-10-16       Impact factor: 53.440

7.  Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain.

Authors:  K L Elkins; C M Bosio; T R Rhinehart-Jones
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 8.  Natural killer (NK) cells in antibacterial innate immunity: angels or devils?

Authors:  Fernando Souza-Fonseca-Guimaraes; Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

Review 9.  Natural Killer Cell Regulation of B Cell Responses in the Context of Viral Infection.

Authors:  Ivayla E Gyurova; Ayad Ali; Stephen N Waggoner
Journal:  Viral Immunol       Date:  2019-12-03       Impact factor: 2.257

10.  Abnormal NK cell lymphocytosis detected after splenectomy: association with repeated infections, relapsing neutropenia, and persistent polyclonal B-cell proliferation.

Authors:  Elisa Granjo; Margarida Lima; Manuela Fraga; Filipe Santos; Conceição Magalhães; Maria Luís Queirós; Ilidia Moreira; Sandra Rocha; Alice Santos Silva; Irene Rebelo; Alexandre Quintanilha; Maria Letícia Ribeiro; Jorge Candeias; Alberto Orfão
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.